New Prevention Guidelines for Genital Mycoplasma?A prevalent, highly drug-resistant STI

Door Jim Smith gepubliceerd op Friday 09 September 08:21

Researchers have found the first evidence of sexually transmitted infection Mycoplasma genitalium in Canada. It’s highly prevalent, inordinately drug-resistant, and clinics aren’t testing for it — until recently there was no standardized test available.

Its symptoms are easily mistaken for chlamydia or gonorrhea. But treating Mycoplasma genitalium with antibiotics aimed at other infections just makes things worse, killing weaker bugs and fostering colonies of resilient superbugs.

The study tested 1,193 men and women at a Toronto STI clinic. About 4.5 per cent of the men and 3.2 per cent of the women tested positive for Mycoplasma genitalium. That sounds small but it would make this one of the most common STIs out there — more than 10 times the rate of syphilis.

And a high proportion of the people tested had drug-resistant strains of Mycoplasma genitalium: 58 per cent were resistant to the antibiotic macrolide; 20 per cent were resistant to fluoroquinolone.

The problem is that the more you use second-line treatments, the more quickly those treatments can become ineffective.

New Prevention Guidelines for Genital Mycoplasma:

  •     Practise safer sex.
  •     No sex until antibiotic treatment is completed and your usual sexual partner has completed treatment.
  •     A follow-up test must be done to make sure that treatment has cleared the infection.
  •     All sexual partners need to be contacted, tested and, if indicated, treated. Even if partners have no symptoms they may be able to transmit infection to other sexual partners.
  • Testing to exclude other sexually transmitted infections is advisable.



Reacties (0) 

Voordat je kunt reageren moet je aangemeld zijn. Login of maak een gratis account aan.